John Prista Freshley

John Prista Freshley Email and Phone Number

Chief Executive Officer @ CURIO Genomics
Ann Arbor, MI, US
John Prista Freshley's Location
Ann Arbor, Michigan, United States, United States
John Prista Freshley's Contact Details

John Prista Freshley personal email

n/a
About John Prista Freshley

Entrepreneur/Company Builder/Leader with 20+ years experience in start-up and emerging bioscience companies.My strengths and true expertise lies in the earliest stage of science commercialization, especially in regions where early capital can be scarce. This is also the challenge I most enjoy. I thrive at:- partnering closely with scientists; - digging deep to learn new science;- developing market and development strategies to leverage the science's full potential; - assembling expert teams with shared purpose, drive and a cohesive culture;- implementing the operations capabilities to support effective and efficient early corporate developmentThe very best days start with a coffee and a new science publication that triggers new learning.

John Prista Freshley's Current Company Details
CURIO Genomics

Curio Genomics

View
Chief Executive Officer
Ann Arbor, MI, US
John Prista Freshley Work Experience Details
  • Curio Genomics
    Chief Executive Officer
    Curio Genomics
    Ann Arbor, Mi, Us
  • Bioscience Navigators
    Chairman
    Bioscience Navigators Sep 2020 - Present
    Ann Arbor, Michigan, Us
    Bioscience Navigators is dedicated to providing hands-on experienced business leadership for breakthrough science from universities and start-ups in often overlooked regions that will create attractive investor returns, the next-generation of bioscience leadership talent, and vibrant and sustainable bioscience ecosystems.With public benefit as a core element of our mission and financial beneficiary of any success, Bioscience Navigators is also able to call on a global network of our biotech "friends and family" to volunteer and provide guidance to our project teams and student scientists considering careers in industry.
  • Akeila Bio
    Executive Chairman
    Akeila Bio Oct 2021 - Present
    Akeila Bio is developing next generation RXR drugs to treat a wide range of disease with major unmet patient needs. Akeila's RXR agonists combine the potency of prior RXR drugs, such as bexarotene, but without the dose-limiting toxicities of hypertriglyceridemia and hypercholesterolemia.
  • Curio Genomics
    Executive Chairman
    Curio Genomics Jan 2020 - Present
    Ann Arbor, Mi, Us
    Curio Genomics is developing powerful new ways to bring genomics insights to crop researchers and seed companies to meet the simultaneous challenges of malnutrition, population growth, and climate change.
  • Cantilever Investors
    Fund Advisor
    Cantilever Investors Jul 2023 - Present
    Ann Arbor, Michigan, Us
    Support Cantilever Investors in identifying and evaluating life science investment opportunities, while also providing direct management expertise to portfolio companies.
  • Venture A5
    International Advisor
    Venture A5 Oct 2019 - Present
    Working with leading research institutes, including the Gulbenkian Institute of Science and NOVA University, in the A5 Corridor from Lisbon-to-Oeiras-to-Cascais focused on to creating value and innovating in the Health and Life Sciences. With leadership support from Nova University and the municipality of Oeiras, Venture A5 will leverage the institutes world-class science and infrastructure to create an environment to nurture entrepreneurship and attract investment.
  • Asalyxa Bio
    Head Of Corporate Development
    Asalyxa Bio May 2020 - Feb 2023
    With my colleagues at Orange Grove Bio, I am excited to help launch another exciting University of Michigan biotech start-up. Asalyxa is developing its neutrophil-targeting delivery platform and lead candidate ASX-100 for ARDS and other critical inflammatory disorders.
  • Orange Grove Bio
    Venture Partner
    Orange Grove Bio Nov 2019 - Feb 2023
    Cincinnati, Ohio, Us
  • Onl Therapeutics
    President & Ceo
    Onl Therapeutics Jun 2013 - Apr 2019
    Ann Arbor, Michigan, Us
    ONL Therapeutics (ONL) is a biopharmaceutical company committed to protecting and improving the vision of patients with a range of retinal diseases and conditions.By advancing a novel breakthrough technology designed to protect photoreceptors against programmed cell death (apoptosis), ONL is pioneering an entirely new approach to preserving sight. It is the first and only company focused on preventing the death of photoreceptors – the root cause of vision loss and the leading cause of blindness.
  • University Of Michigan
    Mentor-In-Residence
    University Of Michigan Feb 2013 - Oct 2013
    Ann Arbor, Michigan, Us
    Work with professors and staff at the University of Michigan to evaluate technology and the potential to launch start-up businesses. Leveraging a career in early phase start-up organizations, I assist faculty and staff in developing business models and plans, securing start-up funding, and building management teams.
  • Compendia Bioscience
    Chief Business Officer
    Compendia Bioscience Feb 2006 - Jun 2013
    Waltham, Ma, Us
    As interim CEO in 2006-2007, I recruited Compendia's management team, led the development of Compendia's company culture, and secured the company's first 10 customers.I also led the company's efforts to secure early funding including $1.2M from Michigan's 21st Century Job Fund and a $2.4M Phase I-II Fast Track SBIR grant from the NIH.With funding secured, the company's scientific founder was able to leave an academic position at the University of Michigan to assume the CEO role.As CBO, I then continued the development of business strategies to complement and leverage Compendia's scientific and technology strategies for the benefit of Compendia's customers and collaborators.Over the past 6+ years, Compendia's revenue has grown steadily and a company of 30+ staff has been consistently profitable for 3+ years with healthy and growing net margins leading to a successful acquisition by Life Technologies.
  • Oncovera Therapeutics, Inc.
    Co-Founder, President & Ceo
    Oncovera Therapeutics, Inc. Oct 2007 - May 2009
    Partnered with industry-leading scientists and lead fundraising and partnering activities focused on the in-licensing and development of cancer drugs utilizing personalized medicine approaches.
  • Genetics Squared, Inc.
    President & Ceo
    Genetics Squared, Inc. May 2004 - Jan 2006
    Led innovative drug development company focused on utilizing proprietary in-silico analysis to effectively develop cancer drugs with personalized medicine approach.
  • Statprobe, Inc.
    Director, Marketing & Corporate Development
    Statprobe, Inc. Sep 2000 - Jun 2004
    Wimbledon, London, Gb
    Led sales, marketing and corporate partnering activities.
  • Grapevine Technologies
    Director Of Marketing
    Grapevine Technologies 1995 - 1999

John Prista Freshley Skills

Business Strategy Biotechnology Start Ups Entrepreneurship Oncology Strategic Partnerships Product Development New Business Development Strategic Planning Business Development Marketing Strategy Lifesciences Commercialization Pharmaceutical Industry Cross Functional Team Leadership Strategic Alliances Marketing Infectious Diseases Cancer Medical Devices Drug Development Genomics R&d Venture Capital Mergers And Acquisitions Clinical Development Management Consulting Clinical Trials Technology Transfer Management Corporate Development Healthcare Licensing Life Sciences

John Prista Freshley Education Details

  • University Of North Carolina At Chapel Hill
    University Of North Carolina At Chapel Hill
    Communications
  • University Of Illinois Urbana-Champaign
    University Of Illinois Urbana-Champaign
    Journalism
  • Dartmouth College
    Dartmouth College
  • Culver Academies
    Culver Academies

Frequently Asked Questions about John Prista Freshley

What company does John Prista Freshley work for?

John Prista Freshley works for Curio Genomics

What is John Prista Freshley's role at the current company?

John Prista Freshley's current role is Chief Executive Officer.

What is John Prista Freshley's email address?

John Prista Freshley's email address is jo****@****ley.net

What is John Prista Freshley's direct phone number?

John Prista Freshley's direct phone number is +173492*****

What schools did John Prista Freshley attend?

John Prista Freshley attended University Of North Carolina At Chapel Hill, University Of Illinois Urbana-Champaign, Dartmouth College, Culver Academies.

What skills is John Prista Freshley known for?

John Prista Freshley has skills like Business Strategy, Biotechnology, Start Ups, Entrepreneurship, Oncology, Strategic Partnerships, Product Development, New Business Development, Strategic Planning, Business Development, Marketing Strategy, Lifesciences.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.